All posts by: Michael Zand

About Michael Zand

Human Stem Cell Patent Covers Ineligible Subject Matter And Work Was … – 4-traders (press release)

Human Stem Cell Patent Covers Ineligible Subject Matter And Work Was …4-traders (press release)WASHINGTON, Sept. 3, 2013 /PRNewswire-USNewswire/ — A patent on human embryonic stem cells held by the Wisconsin Alumni Research Foundation (WARF) “covers ineligible subject matter and was anticipated by and obvious” in view of earlier … and more …read more   &nbs… Continue reading

2013-09-03 NEWS

Human Stem Cell Patent Covers Ineligible Subject Matter And Work Was … – 4-traders (press release)

Human Stem Cell Patent Covers Ineligible Subject Matter And Work Was …4-traders (press release)WASHINGTON, Sept. 3, 2013 /PRNewswire-USNewswire/ — A patent on human embryonic stem cells held by the Wisconsin Alumni Research Foundation (WARF) “covers ineligible subject matter and was anticipated by and obvious” in view of earlier … and more …read more   &nbs… Continue reading

2013-09-03 NEWS

4 UCLA stem cell researchers receive CIRM Early Translational grants – EurekAlert (press release)

4 UCLA stem cell researchers receive CIRM Early Translational grantsEurekAlert (press release)The grants are part of CIRM’s Early Translational Research Initiative, which aims to advance promising, innovative discoveries using stem cells. In this “early translation” phase, scientists are expected to do research that will result in the … …read more   &nbs… Continue reading

2013-09-03 NEWS

New recombinant antibody can isolate stem cells from umbilical cord blood – EurekAlert (press release)

New recombinant antibody can isolate stem cells from umbilical cord bloodEurekAlert (press release)New Rochelle, NY, September 3, 2013輸 new recombinant antibody can detect and isolate mesenchymal stem cells (MSCs), a nonembryonic source of stem cells with promising applications in tissue engineering, blood stem cell transplantation, and … …read more   &nbs… Continue reading

2013-09-03 NEWS

Florida Hospital launches stem cell study to reduce side effects of stroke – Orlando Business Journal

Florida Hospital launches stem cell study to reduce side effects of strokeOrlando Business JournalFlorida Hospital is hoping to get one step closer to minimizing the long-term side effects of a stroke. Orlando-based Florida Hospital Neuroscience Institute is launching a clinical trial to study the safety and efficacy of administering adult stem … …read more   &nbs… Continue reading

2013-09-03 NEWS

Histogen’s Method of Generating Multipotent Stem Cells Receives US Patent – PR Web (press release)

Histogen’s Method of Generating Multipotent Stem Cells Receives US PatentPR Web (press release)The issued patent covers Histogen’s method of triggering the de-differentiation of fibroblast cells into multipotent stem cells through low oxygen and special culture conditions. The resulting multipotent cells naturally secrete a variety of soluble … …read more   &nbs… Continue reading

2013-09-03 NEWS

Histogen’s Method of Generating Multipotent Stem Cells Receives US Patent – DigitalJournal.com

Histogen’s Method of Generating Multipotent Stem Cells Receives US PatentDigitalJournal.comHistogen, Inc., a regenerative medicine company developing innovative therapies for conditions including hair loss and cancer, today announced that the United States Patent & Trademark Office has issued patent 8,524,494, entitled “Low Oxygen Tension … …read more   &nbs… Continue reading

2013-09-03 NEWS